REFERENCES

  1. Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002;96(1):1-6. doi: 10.1053/rmed.2001.1207.
  2. Harknett EC, Chang WYC, Byrnes S, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 104(11):971-9. doi: 10.1093/qjmed/hcr116.
  3. Lee J. Lymphangioleiomyomatosis. The Merck Manual Online. Retrieved from The Merck Manuals Online Medical Library Database. Updated May 2018.https://www.merckmanuals.com/professional/pulmonary-disorders/interstitial-lung-disease/lymphangioleiomyomatosis.
  4. Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006;173(1):105-11. doi: 10.1164/rccm.200409-1298OC.

See also

Test your Knowledge
Test your knowledge

Take the test

Lung X-Ray Example
Rad Rounds Mobile App

Download the app

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media